Loading insider details...
Beta
Latest Form 4 (Jan 5, 2026): Grant/Award of 125,000 CMPX shares, $646.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 5, 2026 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 125,000 | $646.3K |
| Feb 13, 2025 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 250,000 | n/a |
| Dec 10, 2024 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 400,000 | $660.0K |
| Oct 10, 2024 | TREVENA INC (TRVN) | Tax Withholding | 17 | $24.99 |
| Sep 17, 2024 | TREVENA INC (TRVN) | Tax Withholding | 3 | $17.85 |